Cargando…

Qianliexin capsule exerts anti‐inflammatory activity in chronic non‐bacterial prostatitis and benign prostatic hyperplasia via NF‐κB and inflammasome

Qianliexin capsule (QLX) is a standardized traditional Chinese herbal preparation that has long been used to treat chronic non‐bacterial prostatitis (CNP) and benign prostatic hyperplasia (BPH). This study investigated the anti‐inflammatory activity of QLX in improving lower urinary tract symptoms (...

Descripción completa

Detalles Bibliográficos
Autores principales: Zang, Linghe, Tian, Fangyuan, Yao, Yuancheng, Chen, Yiran, Shen, Yuan, Han, Mingyu, Meng, Zhaoqing, Fan, Shengci, Zhang, Xinyi, Cai, Tian, Gao, Qi, Zhang, Yuwei, Lu, Jincai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184730/
https://www.ncbi.nlm.nih.gov/pubmed/33982874
http://dx.doi.org/10.1111/jcmm.16599
_version_ 1783704638498799616
author Zang, Linghe
Tian, Fangyuan
Yao, Yuancheng
Chen, Yiran
Shen, Yuan
Han, Mingyu
Meng, Zhaoqing
Fan, Shengci
Zhang, Xinyi
Cai, Tian
Gao, Qi
Zhang, Yuwei
Lu, Jincai
author_facet Zang, Linghe
Tian, Fangyuan
Yao, Yuancheng
Chen, Yiran
Shen, Yuan
Han, Mingyu
Meng, Zhaoqing
Fan, Shengci
Zhang, Xinyi
Cai, Tian
Gao, Qi
Zhang, Yuwei
Lu, Jincai
author_sort Zang, Linghe
collection PubMed
description Qianliexin capsule (QLX) is a standardized traditional Chinese herbal preparation that has long been used to treat chronic non‐bacterial prostatitis (CNP) and benign prostatic hyperplasia (BPH). This study investigated the anti‐inflammatory activity of QLX in improving lower urinary tract symptoms (LUTS) associated with CNP and BPH. Rat models of CNP and BPH were induced by oestradiol or testosterone (hormonal imbalance) or chemical inflammation (carrageenan). QLX significantly relieved LUTS in CNP and BPH rat model by reducing prostate enlargement, epithelial thickness, pain response time, urine volume and bleeding time, and by improving prostatic blood flow. The expression of the pro‐inflammatory cytokines interleukin (IL)‐1β and tumour necrosis factor (TNF)‐α, the pro‐inflammatory transcription factor nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB), and inflammasome components (NLRP3, caspase‐1 and ASC) in CNP and BPH tissues was reduced by QLX addition. QLX treatment was followed by reduced cellular malondialdehyde and increased superoxide dismutase, catalase and glutathione peroxidase activity, consistent with antioxidant activity. Increases in Beclin‐1 expression and the LC3II/I ratio following QLX treatment indicated that autophagy had been induced. QLX relieved LUTS in CNP and BPH rat models by inhibiting inflammation. The underlying mechanisms included inhibition of inflammasome activation, NF‐κB activation, oxidant stress and autophagy.
format Online
Article
Text
id pubmed-8184730
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81847302021-06-15 Qianliexin capsule exerts anti‐inflammatory activity in chronic non‐bacterial prostatitis and benign prostatic hyperplasia via NF‐κB and inflammasome Zang, Linghe Tian, Fangyuan Yao, Yuancheng Chen, Yiran Shen, Yuan Han, Mingyu Meng, Zhaoqing Fan, Shengci Zhang, Xinyi Cai, Tian Gao, Qi Zhang, Yuwei Lu, Jincai J Cell Mol Med Original Articles Qianliexin capsule (QLX) is a standardized traditional Chinese herbal preparation that has long been used to treat chronic non‐bacterial prostatitis (CNP) and benign prostatic hyperplasia (BPH). This study investigated the anti‐inflammatory activity of QLX in improving lower urinary tract symptoms (LUTS) associated with CNP and BPH. Rat models of CNP and BPH were induced by oestradiol or testosterone (hormonal imbalance) or chemical inflammation (carrageenan). QLX significantly relieved LUTS in CNP and BPH rat model by reducing prostate enlargement, epithelial thickness, pain response time, urine volume and bleeding time, and by improving prostatic blood flow. The expression of the pro‐inflammatory cytokines interleukin (IL)‐1β and tumour necrosis factor (TNF)‐α, the pro‐inflammatory transcription factor nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB), and inflammasome components (NLRP3, caspase‐1 and ASC) in CNP and BPH tissues was reduced by QLX addition. QLX treatment was followed by reduced cellular malondialdehyde and increased superoxide dismutase, catalase and glutathione peroxidase activity, consistent with antioxidant activity. Increases in Beclin‐1 expression and the LC3II/I ratio following QLX treatment indicated that autophagy had been induced. QLX relieved LUTS in CNP and BPH rat models by inhibiting inflammation. The underlying mechanisms included inhibition of inflammasome activation, NF‐κB activation, oxidant stress and autophagy. John Wiley and Sons Inc. 2021-05-13 2021-06 /pmc/articles/PMC8184730/ /pubmed/33982874 http://dx.doi.org/10.1111/jcmm.16599 Text en © 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Zang, Linghe
Tian, Fangyuan
Yao, Yuancheng
Chen, Yiran
Shen, Yuan
Han, Mingyu
Meng, Zhaoqing
Fan, Shengci
Zhang, Xinyi
Cai, Tian
Gao, Qi
Zhang, Yuwei
Lu, Jincai
Qianliexin capsule exerts anti‐inflammatory activity in chronic non‐bacterial prostatitis and benign prostatic hyperplasia via NF‐κB and inflammasome
title Qianliexin capsule exerts anti‐inflammatory activity in chronic non‐bacterial prostatitis and benign prostatic hyperplasia via NF‐κB and inflammasome
title_full Qianliexin capsule exerts anti‐inflammatory activity in chronic non‐bacterial prostatitis and benign prostatic hyperplasia via NF‐κB and inflammasome
title_fullStr Qianliexin capsule exerts anti‐inflammatory activity in chronic non‐bacterial prostatitis and benign prostatic hyperplasia via NF‐κB and inflammasome
title_full_unstemmed Qianliexin capsule exerts anti‐inflammatory activity in chronic non‐bacterial prostatitis and benign prostatic hyperplasia via NF‐κB and inflammasome
title_short Qianliexin capsule exerts anti‐inflammatory activity in chronic non‐bacterial prostatitis and benign prostatic hyperplasia via NF‐κB and inflammasome
title_sort qianliexin capsule exerts anti‐inflammatory activity in chronic non‐bacterial prostatitis and benign prostatic hyperplasia via nf‐κb and inflammasome
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184730/
https://www.ncbi.nlm.nih.gov/pubmed/33982874
http://dx.doi.org/10.1111/jcmm.16599
work_keys_str_mv AT zanglinghe qianliexincapsuleexertsantiinflammatoryactivityinchronicnonbacterialprostatitisandbenignprostatichyperplasiavianfkbandinflammasome
AT tianfangyuan qianliexincapsuleexertsantiinflammatoryactivityinchronicnonbacterialprostatitisandbenignprostatichyperplasiavianfkbandinflammasome
AT yaoyuancheng qianliexincapsuleexertsantiinflammatoryactivityinchronicnonbacterialprostatitisandbenignprostatichyperplasiavianfkbandinflammasome
AT chenyiran qianliexincapsuleexertsantiinflammatoryactivityinchronicnonbacterialprostatitisandbenignprostatichyperplasiavianfkbandinflammasome
AT shenyuan qianliexincapsuleexertsantiinflammatoryactivityinchronicnonbacterialprostatitisandbenignprostatichyperplasiavianfkbandinflammasome
AT hanmingyu qianliexincapsuleexertsantiinflammatoryactivityinchronicnonbacterialprostatitisandbenignprostatichyperplasiavianfkbandinflammasome
AT mengzhaoqing qianliexincapsuleexertsantiinflammatoryactivityinchronicnonbacterialprostatitisandbenignprostatichyperplasiavianfkbandinflammasome
AT fanshengci qianliexincapsuleexertsantiinflammatoryactivityinchronicnonbacterialprostatitisandbenignprostatichyperplasiavianfkbandinflammasome
AT zhangxinyi qianliexincapsuleexertsantiinflammatoryactivityinchronicnonbacterialprostatitisandbenignprostatichyperplasiavianfkbandinflammasome
AT caitian qianliexincapsuleexertsantiinflammatoryactivityinchronicnonbacterialprostatitisandbenignprostatichyperplasiavianfkbandinflammasome
AT gaoqi qianliexincapsuleexertsantiinflammatoryactivityinchronicnonbacterialprostatitisandbenignprostatichyperplasiavianfkbandinflammasome
AT zhangyuwei qianliexincapsuleexertsantiinflammatoryactivityinchronicnonbacterialprostatitisandbenignprostatichyperplasiavianfkbandinflammasome
AT lujincai qianliexincapsuleexertsantiinflammatoryactivityinchronicnonbacterialprostatitisandbenignprostatichyperplasiavianfkbandinflammasome